NCT02354612 2021-02-15Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 TrialTracon Pharmaceuticals Inc.No longer available
NCT01369433 2020-09-01A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsAVEO Pharmaceuticals, Inc.Phase NA Terminated225 enrolled 7 charts